Ads

 

Ads

 

Ads

 

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biopharmaceutical Companies 2024
Metatag Abstract
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.
  1. Immunovant

    World Rank (Jan-05-2024)
    2,674
    Market Cap (Jan-05-2024)
    5.626 Billion USD
    World Rank (Jul-30-2023)
    4,418
    Market Cap (Jul-30-2023)
    2.942 Billion USD
    World Rank (Dec-25-2022)
    7,090
    Market Cap (Dec-25-2022)
    1.328 Billion USD
    World Rank (Jan-07-2022)
    9,880
    Market Cap (Jan-07-2022)
    0.92 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -156 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile
    Immunovant is a Clinical Stage Biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The headquarters is in USA.
  2. Hualan Biological Engineering

    World Rank (Jan-05-2024)
    2,715
    Market Cap (Jan-05-2024)
    5.501 Billion USD
    World Rank (Jul-30-2023)
    2,567
    Market Cap (Jul-30-2023)
    5.908 Billion USD
    World Rank (Dec-25-2022)
    2,562
    Market Cap (Dec-25-2022)
    5.408 Billion USD
    World Rank (Jan-07-2022)
    2,153
    Market Cap (Jan-07-2022)
    8.42 Billion USD
    Annual Revenue in USD
    633 Million USD
    Annual Operating Income in USD
    209 Million USD
    Annual Net Income in USD
    151 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Biopharmaceutical company with headquarters is in China.
  3. Iveric Bio

    World Rank (Jan-05-2024)
    2,731
    World Rank (Jul-30-2023)
    2,731
    Market Cap (Jul-30-2023)
    5.510 Billion USD
    World Rank (Dec-25-2022)
    4,099
    Market Cap (Dec-25-2022)
    2.983 Billion USD
    World Rank (Jan-07-2022)
    7,176
    Market Cap (Jan-07-2022)
    1.61 Billion USD
    Annual Operating Income in USD
    -189 Million USD
    Annual Net Income in USD
    -185 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile

    Iveric Bio is an Innovative Biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with significant unmet medical needs. Iveric Bio 163 employees as on 2022. The headquarters is in USA.

    Astellas Pharma Inc. (TSE: 4503) has completed the acquisition of IVERIC bio, Inc. (NASDAQ: ISEE) on July 11, 2023 and the acquisition price of the same was 5.9 billion USD.

  4. Walvax Biotechnology

    World Rank (Jan-05-2024)
    2,859
    Market Cap (Jan-05-2024)
    5.127 Billion USD
    World Rank (Jul-30-2023)
    2,449
    Market Cap (Jul-30-2023)
    6.251 Billion USD
    World Rank (Dec-25-2022)
    1,641
    Market Cap (Dec-25-2022)
    9.186 Billion USD
    World Rank (Jan-07-2022)
    1,379
    Market Cap (Jan-07-2022)
    14.62 Billion USD
    Annual Revenue in USD
    713 Million USD
    Annual Operating Income in USD
    187 Million USD
    Annual Net Income in USD
    102 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Biotechnology company with headquarters is in China.
  5. Arena Pharmaceuticals

    World Rank (Jan-05-2024)
    2,949
    World Rank (Jul-30-2023)
    2,949
    World Rank (Dec-25-2022)
    2,949
    World Rank (Jan-07-2022)
    2,949
    Market Cap (Jan-07-2022)
    5.74 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -616 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Bio-pharmaceutical company with headquarters is in California, USA.

  6. Shanghai Junshi Biosciences

    World Rank (Jan-05-2024)
    3,008
    Market Cap (Jan-05-2024)
    4.826 Billion USD
    World Rank (Jul-30-2023)
    2,973
    Market Cap (Jul-30-2023)
    5.002 Billion USD
    World Rank (Dec-25-2022)
    2,075
    Market Cap (Dec-25-2022)
    6.872 Billion USD
    World Rank (Jan-07-2022)
    2,456
    Market Cap (Jan-07-2022)
    7.22 Billion USD
    Annual Revenue in USD
    204 Million USD
    Annual Operating Income in USD
    -381 Million USD
    Annual Net Income in USD
    -334 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Shanghai Junshi Biosciences is an Innovation Driven Biopharmaceutical company. The company annual revenue is 111 million USD and 1,357 employee as on 2020. The headquarters is in China.
  7. Nuvalent Inc.

    World Rank (Jan-05-2024)
    3,133
    Market Cap (Jan-05-2024)
    4.610 Billion USD
    World Rank (Jul-30-2023)
    4,632
    Market Cap (Jul-30-2023)
    2.756 Billion USD
    World Rank (Dec-25-2022)
    6,273
    Market Cap (Dec-25-2022)
    1.605 Billion USD
    World Rank (Jan-07-2022)
    11,341
    Market Cap (Jan-07-2022)
    0.71 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -86 Million USD
    Annual Net Income in USD
    -82 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Nuvalent, Inc., is a clinical stage biopharmaceutical company, and it develops therapies for patients with cancer.

    The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts, USA.

  8. Perrigo Company

    World Rank (Jan-05-2024)
    3,172
    Market Cap (Jan-05-2024)
    4.552 Billion USD
    World Rank (Jul-30-2023)
    3,003
    Market Cap (Jul-30-2023)
    4.946 Billion USD
    World Rank (Dec-25-2022)
    3,011
    Market Cap (Dec-25-2022)
    4.446 Billion USD
    World Rank (Jan-07-2022)
    3,057
    Market Cap (Jan-07-2022)
    5.45 Billion USD
    Annual Revenue in USD
    4,451 Million USD
    Annual Operating Income in USD
    121 Million USD
    Annual Net Income in USD
    -140 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Perrigo is a leading global healthcare company, focused on providing value to its customers and consumers by delivering Quality Affordable Healthcare Products. Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. Perrigo is the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market.
  9. Syneos Health

    World Rank (Jan-05-2024)
    3,312
    World Rank (Jul-30-2023)
    3,312
    Market Cap (Jul-30-2023)
    4.404 Billion USD
    World Rank (Dec-25-2022)
    3,511
    Market Cap (Dec-25-2022)
    3.681 Billion USD
    World Rank (Jan-07-2022)
    1,964
    Market Cap (Jan-07-2022)
    9.52 Billion USD
    Annual Revenue in USD
    5,393 Million USD
    Annual Operating Income in USD
    459 Million USD
    Annual Net Income in USD
    266 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Syneos Health is a Biopharmaceutical Solutions company. It having approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. The headquarters is in USA.

    Syneos Health was acquired by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital for $43.00 per share in cash in a transaction valued at approximately $7.1 billion, including outstanding debt. Definitive agreement related to the acquisition was made in May-2023.

  10. Insmed

    World Rank (Jan-05-2024)
    3,388
    Market Cap (Jan-05-2024)
    4.167 Billion USD
    World Rank (Jul-30-2023)
    4,448
    Market Cap (Jul-30-2023)
    2.913 Billion USD
    World Rank (Dec-25-2022)
    4,526
    Market Cap (Dec-25-2022)
    2.621 Billion USD
    World Rank (Jan-07-2022)
    4,793
    Market Cap (Jan-07-2022)
    3.05 Billion USD
    Annual Revenue in USD
    245 Million USD
    Annual Operating Income in USD
    -478 Million USD
    Annual Net Income in USD
    -481 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Insmed is a Biopharmaceutical company. The headquarters is in USA.

Share

Ads